By Emily Mae Czachor News Editor Emily Mae Czachor is a reporter and news editor at CBSNews.com. She typically covers breaking news, extreme weather and climate. Emily Mae previously wrote for outlets like the Los Angeles Times, BuzzFeed and Newsweek. Read Full Bio Updated on: March 10, 2026 / 1:50 PM EDT / CBS News Add CBS News on Google Novo Nordisk, the pharmaceutical company behind Ozempic, has received a warning letter from the U.S. Food and Drug Administration over issues with its procedures for reporting potential side effects of the flagship diabetes drug, which is also prescribed for weight loss.  In the letter , dated March 5, the FDA cited three deaths among patients receiving semaglutide, the generic name for the medication in Novo Nordisk's Ozempic and Wegovy, which were allegedly not reported properly to the agency. Those deaths included one suicide, according to the FDA. Another instance involved a patient that reported suicidal ideations while taking semaglutide.…